What if there was a simple blood test that could find cancer early?

Learn More About Cchek TM
About

ITUS Corporation is developing a platform called Cchek™, a series of inexpensive non-invasive blood tests for the early detection of cancer.

Logo Check

October 2015

Initial biomarker results for breast cancer

February 2016

Christiana Care joins biomarker study

April 2016

Efficacy shown for lung cancer

July 2016

Virtua Healthcare joins biomarker study

September 2016

Efficacy shown for melanoma, colon and ovarian cancers

October 2016

Efficacy shown for liver, thyroid, and pancreatic cancers

November 2016

Efficacy shown for 6 additional cancer types

December 2016

Preliminary cancer patient study results announced

December 2016

MD Anderson Cooper joins biomarker study

In Progress

Sign up for email Updates

Be The First to Receive Breaking News

Sign Up Now
Logo Itus

Latest News & Events

ITUS Corporation Successfully Completes $3.6 Million Public Offering

Read More...

ITUS Corporation Announces Pricing of Public Offering of up to 3.5 million shares of Common Stock

Read More...

ITUS Corporation Announces Proposed Public Offering of Common Stock

Read More...

Stock Data

View Investors Relations
NASDAQ: ITUS
Price
Change

Cancer of the Lung, Breast, Colon, Prostate, and Stomach are the five most prevalent cancers worldwide.